Author

Himanshu Garg

Texas Tech University Health Sciences Center. El Paso - Cited by 1,754

Biography

Dr. Himanshu Garg is currently working at Biomedical Sciences Department. Himanshu Garg is research interests includes Biomedical Sciences in Immunodeficiency. Himanshu Garg serving as an editorial member and reviewer of several international reputed journals. Himanshu Garg has successfully completed his Administrative responsibilities. Himanshu Garg has authored of many research articles/books related to Medicine.
Title
Cited by
Year
HIV-1 induced bystander apoptosis
H Garg, J Mohl, A JoshiViruses 4 (11), 3020-3043, 2012201
165
2012
Strategies for targeted nonviral delivery of siRNAs in vivo
SS Kim, H Garg, A Joshi, N ManjunathTrends in Molecular Medicine 15 (11), 491-500, 2009200
142
2009
Development of virus-like-particle vaccine and reporter assay for Zika virus
H Garg, M Sedano, G Plata, EB Punke, A JoshiJournal of virology 91 (20), 10.1128/jvi. 00834-17, 2017201
78
2017
Virus like particles (VLP) as multivalent vaccine candidate against chikungunya, Japanese encephalitis, yellow fever and zika virus
H Garg, T Mehmetoglu-Gurbuz, A JoshiScientific Reports 10 (1), 4017, 2020202
69
2020
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
K Loomis, B Smith, Y Feng, H Garg, A Yavlovich, R Campbell-Massa, ...Experimental and molecular pathology 88 (2), 238-249, 2010201
50
2010
HIV ENV glycoprotein-mediated bystander apoptosis depends on expression of the CCR5 co-receptor at the cell surface and ENV fusogenic activity
A Joshi, AM Nyakeriga, R Ravi, H GargJournal of Biological Chemistry 286 (42), 36404-363, 2011201
41
2011
Host and viral factors in HIV-mediated bystander apoptosis
H Garg, A JoshiViruses 9 (8), 237, 2017201
39
2017
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
H Garg, R Salcedo, G Trinchieri, R BlumenthalCancer gene therapy 17 (3), 155-163, 2010201
38
2010
Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release
A Joshi, H Garg, SD Ablan, EO FreedJournal of Biological Chemistry 286 (), 29861-29871, 2011201
34
2011
Recent advances in Zika virus vaccines
H Garg, T Mehmetoglu-Gurbuz, A JoshiViruses 10 (11), 631, 2018201
34
2018
Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy
H Garg, M Viard, A Jacobs, R BlumenthalCurrent topics in medicinal chemistry 11 (24), 2947-2958, 2011201
34
2011
TCR‐induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56lck residues
AM Nyakeriga, H Garg, A JoshiCytometry Part A 81 (9), 797-805, 2012201
33
2012
Cardiovascular complications of HIV infection and treatment
H Garg, A Joshi, D MukherjeeCardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2013201
33
2013
HIV-1 Env glycoprotein phenotype along with immune activation determines CD4 T cell loss in HIV patients
A Joshi, M Sedano, B Beauchamp, EB Punke, ZD Mulla, A Meza, ...The Journal of Immunology 196 (4), 1768-1779, 2016201
26
2016
HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc
H Garg, RTC Lee, S Maurer-Stroh, A JoshiVirology 493, 86-99, 2016201
25
2016
CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
A Joshi, EB Punke, M Sedano, B Beauchamp, R Patel, C Hossenlopp, ...Scientific reports 7 (1), 232, 2017201
24
2017
Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice
H Garg, A Joshi, C Ye, P Shankar, N ManjunathVirology journal 8, 1-13, 2011201
23
2011
Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants
H Garg, A Joshi, R BlumenthalAIDS research and human retroviruses 25 (8), 811-817, 2009200
21
2009
Genetic signatures of HIV-1 envelope-mediated bystander apoptosis
A Joshi, RTC Lee, J Mohl, M Sedano, WX Khong, OT Ng, S Maurer-Stroh, ...Journal of Biological Chemistry 289 (5), 2497-2514, 2014201
19
2014
Capsid containing virus like particle vaccine against Zika virus made from a stable cell line
H Garg, T Mehmetoglu-Gurbuz, GM Ruddy, A JoshiVaccine 37 (48), 7123-7131, 2019201
18
2019

Referred From: https://scholar.google.com/citations?user=GuTl1aMAAAAJ&hl=en

Cited by
Citations 1754
h-index 26
i10-index 39
Recommended Journals
Open Access Journals